Medivir
Medivir: Birinapant is given attention at ASCO (Redeye)
2019-05-16 11:10
Results from the completed Phase I combination study with birinapant and Keytruda will be presented during the ASCO conference in Chicago. The abstract released last night confirms what has previously been announced from Medivir.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se